Treatment of Malignant Tumors With NK Cell
Phase 1
- Conditions
- Malignancy
- Interventions
- Biological: Decitabine combined with NK cell infusion
- First Posted Date
- 2021-12-03
- Last Posted Date
- 2021-12-03
- Lead Sponsor
- Shenzhen University General Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT05143125
- Locations
- π¨π³
Shenzhen University General hospital, Shenzhen, Guangdong, China
Allogeneic CD19 CAR-T Cells for the Treatment of Relapsed/Refractory B-cell Lymphoma
Phase 1
- Conditions
- Non-hodgkin Lymphoma,B Cell
- Interventions
- Biological: Allogeneic CD19 CR-T cell
- First Posted Date
- 2021-12-03
- Last Posted Date
- 2021-12-03
- Lead Sponsor
- Shenzhen University General Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT05143112
- Locations
- π¨π³
Li Yu, Shenzhen, Guangdong, China
CD276-targeted Chimeric Antigen Receptor T Cells in Treatment With Advanced Pancreatic Cancer
Phase 1
- Conditions
- Advanced Pancreatic Carcinoma
- Interventions
- Biological: CD276 CAR-T cells
- First Posted Date
- 2021-12-03
- Last Posted Date
- 2021-12-03
- Lead Sponsor
- Shenzhen University General Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT05143151
- Locations
- π¨π³
Li Yu, Shenzhen, Guangdong, China
Dual Target CAR-T Cells in B-cell Acute Lymphoblastic Leukemia
Phase 1
- Conditions
- Refractory B Acute Lymphoblastic LeukemiaDual-target CAR-T CellsB ALLRelapse
- Interventions
- Biological: Dual target CAR-T cell therapy
- First Posted Date
- 2021-01-26
- Last Posted Date
- 2021-01-26
- Lead Sponsor
- Shenzhen University General Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT04723901
- Locations
- π¨π³
Shenzhen University General hospital, Shenzhen, Guangdong, China
Treatment of Malignant Tumors With Antigen Peptide-specific DC-CTL Cells and Decitabine
Phase 1
- Conditions
- Malignant Tumor
- Interventions
- Biological: DC-CTL
- First Posted Date
- 2020-12-17
- Last Posted Date
- 2020-12-17
- Lead Sponsor
- Shenzhen University General Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT04672473
- Locations
- π¨π³
Shenzhen University General Hospital, Shenzhen, Guangdong, China
Β© Copyright 2025. All Rights Reserved by MedPath